Showing results (51-60 of 84) with videos related to

Sort By:
Pageof 9
Journal of Experimental & Clinical Cancer Research : CR|August 4, 2001
Cost of de novo acute myeloid leukemia induction therapy in adults: analysis of EORTC-GIMEMA AML10 and FLANG regimensM Clavio, S Quintino, B Masoudi, et al.
The New England Journal of Medicine|January 26, 1995
Autologous or allogeneic bone marrow transplantation compared with intensive chemotherapy in acute myelogenous leukemia. European Organization for Research and Treatment of Cancer (EORTC) and the Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto (GIMEMA) Leukemia Cooperative GroupsR A Zittoun, F Mandelli, R Willemze, et al.
European Journal of Haematology|January 1, 1995
Clinical implications of cytokine and soluble receptor measurements in patients with newly-diagnosed aggressive non-Hodgkin's lymphomaR Stasi, L Zinzani, P Galieni, et al.
Leukemia|April 1, 1987
Human lymphoblastoid interferon for hairy cell leukemia: results from the Italian Cooperative GroupE E Damasio, C Bernasconi, G L Castoldi, et al.
Bone Marrow Transplantation|September 1, 1988
Relapse after allogeneic bone marrow transplantation for Philadelphia chromosome positive chronic myeloid leukemia: cytogenetic analysis of 24 patientsA Zaccaria, G Rosti, M Sessarego, et al.
Recenti Progressi in Medicina|April 29, 1998
Five day intermittent vs seven day continuous 2-chlorodeoxyadenosine infusion for the treatment of hairy cell leukemia. A study by Italian Group for the Hairy Cell LeukemiaE E Damasio, L Resegotti, B Masoudi, et al.
Bone Marrow Transplantation|September 14, 2004
The rationale behind autologous autoimmune hematopoietic stem cell transplant conditioning regimens: concerns over the use of total-body irradiation in systemic sclerosisR K Burt, D Patel, J Thomas, et al.
Acta Haematologica|January 1, 1978
Lymphoid antigens on blast cells in the agranular metamorphosis of chronic myelogenous leukaemiaA Bacigalupo, G Santini, G Piaggio, et al.
Experimental Hematology|October 1, 1983
Treatment of severe aplastic anemia with sequential immunosuppressionA M Marmont, A Bacigalupo, M T Van Lint, et al.
European Journal of Cancer (Oxford, England : 1990)|February 16, 2000
Centre effect on treatment outcome for patients with untreated acute myelogenous leukaemia? An analysis of the AML 8A Study of the Leukemia Cooperative Group of the EORTC and GIMEMA. European Organization for Research and Treatment of Cancer (EORTC) Leukemia Cooperative Group and the Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto (GIMEMA)S Keating, T de Witte, S Suciu, et al.
Pageof 9